Erythropoietin Treatment of Anemia Associated with Multiple MyelomaHeinz Ludwig, Ursula Barnas, P Höcker et al.|New England Journal of Medicine|1990Cited by 450
Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose ChemotherapyJohannes Drach, H. Huber, Michael Fiegl et al.|Blood|1998Cited by 321
Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]Heinz Ludwig, J. C. Schuster, E. Fritz et al.|Blood|1994Cited by 193
Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]Heinz Ludwig, J. C. Schuster, E. Fritz et al.|Blood|1994Cited by 129